Cresco Labs CFO stepped down and Cresco Labs stock trades at EUR 0.59 versus EUR 0.59

Published on 10/08/2026 at 12:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached USD 173.34 million, up 15.00 percent sequentially. Cresco Labs stock costs EUR 0.59 on October 8, 2026 versus EUR 0.59 prior close.

CL, CA22587M1068, Illustration mit AI erstellt.

Cresco Labs (ISIN CA22587M1068) was unchanged at EUR 0.59 at Lang & Schwarz on October 8, 2026 at 12:04 p.m. CEST, versus the EUR 0.59 prior close, while CFO Sharon Schuller had stepped down on October 6, 2026, according to Benzinga. The leadership change came alongside a quarter in which revenue and adjusted profitability both improved.

Revenue growth reached 15.00 percent

In the second quarter of 2026, Cresco Labs generated USD 173.34 million in revenue, up 15.00 percent sequentially, according to Benzinga. Adjusted EBITDA reached USD 40.00 million, up 20.00 percent sequentially, while operating cash flow was USD 15.00 million for the quarter.

The margin picture was strong but included one-time benefits that management did not expect to repeat. Adjusted gross profit was USD 89.00 million, equal to a 52.00 percent margin, and management guided to a gross margin in the high 40s to 50.00 percent for the third quarter.

Leadership change meets listing plans

Schuller announced her decision to step down as chief financial officer during the October 6 earnings call, and Cresco Labs said it had begun searching for a successor. Mark Stortz is serving as interim CFO, according to a September 24 company release.

The proposed governance changes remain tied to a potential senior U.S. exchange listing. In its Cresco Labs release dated September 24, 2026, the company said shareholders would vote on a new parent company, a potential move of the domicile to Delaware and an extension of the multiple-voting-share sunset period. The annual and special meeting is scheduled for October 30, 2026.

Stock stays unchanged in Europe

The euro quotation stayed at EUR 0.59 at Lang & Schwarz on October 8, 2026 at 12:04 p.m. CEST, unchanged versus the EUR 0.59 prior close dated October 7, 2026. The primary Canadian listing was last quoted at CAD 0.94 on October 7, 2026 at 11:40 a.m. EDT, with a CAD 0.88 to CAD 3.12 52-week range and CAD 333.0 million market capitalization.

The further course of trading is shown by the continuously updated real-time quote of Cresco Labs stock.